Photon-counting CT scans for finding small lung blood clots
Compares a new CT scanner with another type in adults with suspected lung clots.
Key facts
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Diagnostic Value of Photon-Counting CT in Subsegmental Pulmonary Embolism
- Status
- Recruiting
- People taking part
- 696 people, planned
- Started
- 1 Jan 2026
- Expected to end
- Jan 2027
- Type of study
- Observational, 2 groups
- Record updated
- 8 May 2026
Who can take part
The trial is looking for adults with signs of a possible sudden blood clot in the lungs (acute pulmonary embolism). It compares photon-counting CT with conventional CT scans.
- Age
- 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- Suspected acute pulmonary embolism. Symptoms such as shortness of breath, low blood oxygen, chest pain, coughing up blood, or fainting, plus abnormal heart tests or pulse oximetry. A revised simplified Geneva score of 3 or more.
- Earlier treatment
- People who need blood thinners for reasons other than blood clots in the veins (VTE) cannot join.
- Main reasons for not taking part
- Need for blood thinners for reasons other than VTE
- Life expectancy less than three months
- Too ill or unstable to have a CT scan
- Allergy to contrast dye, weak kidneys (creatinine clearance < 30 mL/min), or long-term dialysis
- Pregnancy
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Age ≥ 18 years
- Clinical manifestations supporting the diagnosis of acute pulmonary embolism, including:; Acute onset or progressive dyspnea Unexplained hypoxemia Chest pain Hemoptysis Syncope or presyncope Combined with abnormal findings on electrocardiogram, echocardiography, or pulse oximetry
- Revised simplified Geneva score ≥ 3
- Written informed consent obtained from the patient or the patient's legally authorized representative
Who cannot take part
- Patients requiring prophylactic or therapeutic doses of anticoagulant medication for reasons other than venous thromboembolism (VTE)
- Patients unable to undergo CT scanning due to severe condition or hemodynamic instability
- History of allergy to contrast media, renal insufficiency (creatinine clearance < 30 mL/min), or ongoing long-term dialysis
- Life expectancy less than three months
- Pregnancy
- Refusal to provide informed consent or inability to complete follow-up for any reason
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Subsegmental pulmonary embolism or photon-counting computed tomography
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pulmonary embolism (PE) is a serious and potentially life-threatening condition caused by blood clots in the lungs. A particular type, subsegmental pulmonary embolism (SSPE), involves very small branches of the pulmonary arteries. Although these clots occur in smaller vessels, their risk of recurrence and complications may be similar to larger clots.
Read full original descriptionShow less
Conventional CT pulmonary angiography (CTPA) is the standard imaging test for suspected PE, but image quality can sometimes be limited by motion artifacts, poor contrast filling, or body habitus, making the detection of SSPE challenging.
Photon-counting computed tomography (PCCT) is a new CT technology that provides higher image resolution, lower radiation dose, and improved visualization of small blood vessels. Early studies suggest PCCT may reduce motion artifacts and increase the accuracy of detecting SSPE compared with conventional CT.
This prospective cohort study will compare PCCT with dual-source CT in patients with suspected acute PE. The study aims to determine whether PCCT improves the detection rate and image quality for SSPE, and whether it can provide more reliable diagnostic information to guide clinical care.
The 2 groups in the trial
- Group 1Title: Conventional CT group
Description: Patients with suspected pulmonary embolism who undergo dual-source or energy-integrating detector CT pulmonary angiography (EID-CTPA).
- Group 2 Title: Photon-counting CT group
Description: Patients with suspected pulmonary embolism who undergo photon-counting computed tomography (PCCT) for diagnosis.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Application of Photon-Counting Computed Tomography in the Diagnosis of Subsegmental Pulmonary Embolism
- Plain-language title
- Photon-counting CT scans for finding small lung blood clotsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07575503, who can take part
- Record updated
- 8 May 2026